Introduction
Fundamental to positive selection in mainstream αβ TCR thymocyte development is the production of a functional TCR capable of interacting with self MHC-peptide complexes (1) . The precise role of peptides and other cellular interactions involving stromal-related molecules which may mediate positive selection events, however, remain unresolved. Several models have been developed to address this including the differential avidity model which postulates that high-avidity interactions between the TCR and MHC-peptide complexes, albeit below the threshold for mature T cell activation, result in negative selection and low-avidity interactions result in positive selection (2, 3) . An alternative to this model is that it is the nature of the selecting peptide-antagonist or agonistthat defines whether a cell will undergo positive or negative
Correspondence to: A. Chidgey
Transmitting editor: T. Hünig
Received 6 December 1996, accepted 25 June 1997 selection. In an MHC class I-restricted model it has been suggested that TCR antagonist peptides induce positive selection (4) although they have been shown to inhibit positive selection in CD4 T cells (5) . This may be due to the nature of the peptide itself. In this respect, agonist and antagonist peptides have been shown to mediate different downstream signaling events upon TCR-peptide-MHC ligation, particularly differential phosphorylation of Zap-70 and c-Cbl (6) . Strong agonist peptides only induced negative selection in the ovalbumin TCR transgenic system, with only antagonist peptides having the ability to induce positive selection (7) , contrary to that found in the lymphocytic choriomeningitis virus (LCMV) system where agonist peptide could induce positive selection (3, 8) to produce functional CD8 T cells (9) . This discrepancy Gates were set according to viable cultured stromal-associated lymphocytes and fresh lymphocytes. CD4 -CD8 ϩ cells were clearly evident at day 4 in the absence of peptide. With 10 -5 M LCMV peptide, the transgenic cells initially down-regulated CD4 within the first 24 h, followed by CD8 and apoptosis (CD4 lo CD8 lo ). By day 3-4, the appearance of CD4 -CD8 ϩ cells was evident.
is likely to be due to differences in TCR-peptide-MHC binding affinity between the two transgenic systems. In a recent review (10) the nature of the selecting peptide has been incorporated into the avidity model suggesting that T cells may interact with a variety of peptide ligands and it is the sum of the signals produced that determines whether a cell will be positively or negatively selected or die by neglect. No evidence exists, however, that any one of these models is exclusively applicable to thymic selection. CD4 and CD8 co-receptors are important in TCR-peptide-MHC interactions during thymic selection through their contribution to the avidity of the MHC-TCR interactions and in signaling events although their precise role is unclear. The differential importance of CD8 in positive but not negative selection of MHC class I-restricted T cells has been described (11, 12) . In particular a critical role for CD8β has been implicated (13) (14) (15) (16) , with transfection experiments using T cell hybridomas showing that CD8αβ heterodimers are more effective in signal transduction than the CD8αα homodimer (17) . Using photoaffinity labeling techniques the greater efficiency as a co-receptor of the CD8αβ heterodimer was proposed to be due to its stronger TCR-ligand binding (18) . Furthermore, kinetics studies on cytotoxic T cell lines have led to the proposal that TCR-ligand interactions can modulate CD8-TCR interactions and subsequently influence the ability of CD8 to act as a co-receptor (19) .
Using a novel cell suspension model for thymic positive selection using adult stroma (9), we have found that nominal peptide enhanced the kinetics and efficiency of positive selection producing phenotypically and functionally mature CD8 ϩ T cells. Co-receptor down-modulation occurred in response to high-avidity interactions at high but non-deleting doses of agonist peptide both at the level of the entire CD8αβ co-receptor and the CD8β chain. Collectively these data highlight the importance of peptide in positive selection, and illustrate the ability of the T cell to modulate co-receptor expression both qualitatively and quantitatively in response to peptide driven MHC-TCR interactions.
Methods

Mice
P14 αβ TCR transgenic mice (specific to the LMCV; H-2D b restricted) (20) were bred onto a non-selecting background (H-2 d ) and were maintained at the Monash University animal house. P14 TCR transgenic mice on a TAP-1-deficient background were a kind gift from Professor S. Tonegawa, Massachusetts Institute of Technology. Ly 5.1 congenic C57Bl6 mice were maintained at the Monash University animal house.
Peptides
The nominal LCMV agonist peptide (amino acids 33-41; KAVYNFATM) was a kind gift from Hanspeter Pircher. The original cysteine at anchor position 41 in the wild-type LCMV peptide was replaced by a methionine to prevent dimer formation.
Stromal cell preparation
Stromal cells from Ly 5.1 congenic C57Bl6 mice (H-2 b ) or CBA-CaH (H-2 k ) mice were freshly prepared by gentle 
Co-culture
The transgenic E17 thymocytes were mixed with the thymic stromal cells at a ratio of 5:1 and co-cultured as hanging drops in inverted Terasaki plates at 37°C, 5% CO 2 and harvested generally at day 5. P14 transgenic thymocytes were distinguished from stromal-associated lymphocytes by the expression of Ly 5.2 or MHC class I (S17.71 anti H-2 k ). Routinely, cells were stained with Ly 5.2-FITC (PharMingen, San Diego, CA), CD8-biotin/TriColor (PharMingen) and CD4-phycoerythrin (PE; PharMingen) or CD4-allophycocyanin and V α 2-PE (PharMingen). Dead cells were gated out using propidium iodide or by a FSC/SSC-defined cell viability gate. Cells were analyzed by flow cytometry using a FACScan (Becton Dickinson, Mountain View, CA).
Functional assays
Co-cultures of P14 H-2 d transgenic thymocytes and freshly purified H-2 b stroma were prepared as described above; however, the purified stroma was irradiated at 3000 rad prior to co-culture to prevent proliferation of stroma-associated lymphocytes. Cells were harvested at day 5 and placed into round-bottom wells of a 96-well plate (5ϫ10 4 cells/well) for 48 h, with IL-2 (25 U) and 5ϫ10 5 irradiated (3000 rad) H-2 b splenocytes pre-pulsed with 10 -5 M LCMV peptide. For the proliferation assay, [ 3 H]thymidine was added for 16 h and 
Statistical analysis
Post co-culture, viable cells were counted under a fluorescence microscope using ethidium bromide/acridine orange and standardized as the number of recovered cells/10 6 original E17 put into culture at day 0. CD8 cell numbers recovered from co-cultures containing no peptide versus cocultures containing various concentrations of nominal peptide were compared using Student's t-test analysis.
Results
Verification of the cell suspension model for in vitro positive selection using adult stroma
A novel cell suspension model for in vitro positive selection was developed using P14 transgenic mice expressing a TCR (V β 8.1, V α 2) specific to the LCMV glycoprotein peptide (amino acid sequence 33-41; KAVYNFATM), restricted to H-2D b , on a non-selecting MHC background (H-2 d or TAP-1-/-) to prevent any prior positive selection signaling, as a source of T cell precursors (9) . These transgenic T cell precursor cells (E17 gestation) on a non-selecting background were cocultured with freshly purified selecting adult stroma in the form of a hanging drop over a period of 4-5 days. TCR hi CD4 -CD8 ϩ T cells develop by day 4 only in the presence of selecting stroma, and these have been shown to be functional both in terms of proliferation and specific lysis of target cells (9) .
Agonist peptide enhances the kinetics of thymic selection at low concentration and induces apoptosis at high concentration
In this model, the presence of the nominal LCMV peptide enhanced positive selection but only in the presence of selecting stroma and had no effect on the transgenic cells cultured alone. Time-course experiments showed that by day 2, transgenic cells cultured alone were comprised almost entirely of CD4 ϩ CD8 ϩ ; any CD4 -CD8 ϩ immature thymocytes present at E17 (day 0) had either converted to the doublepositive phenotype or disappeared in culture (Fig. 1A) . By day 3, many of the transgenic cells cultured alone or with H-2 b stromal cells without exogenous peptide remained at the double-positive stage of differentiation or were apoptotic as defined by the CD4 lo CD8 lo phenotype (22) . In co-culture with selecting H-2 b stroma but no nominal peptide, CD4 -CD8 ϩ cells were first clearly evident at day 4 ( Fig. 1B) , consistent with in vivo data (23) . With H-2 b stroma and 10 -5 M LCMV, within the first 24 h negative selection was evident, with most of the CD4 ϩ CD8 ϩ transgenic cells undergoing an initial marked down-regulation of CD4. Over the following 24 h of culture, CD8 down-regulation was also evident with cells taking on the typical apoptotic phenotype (CD4 lo CD8 lo ), some of these falling into the CD8 ϩ gate at day 2 (Fig. 1C) . Positive selection, however, was first clearly evident by day 3, up to 24 h earlier than in the absence of nominal peptide. By day 6 these CD4 -CD8 ϩ cells made up~42% of the total cell population (Fig. 1C) . The reduced recovered cell number in the stromal co-cultures in the first 2 days is due to removal of dead or dying cells by macrophages in the stromal cell preparations (Table 1 ). Presumably this cell death is due to neglect in the absence of peptide and apoptosis in the presence of high concentrations of peptide. By day 4 transgenic cell numbers remained relatively stable, indicating that the CD8 ϩ cells selected were not a transient cell population. Although total cell numbers remain similar by day 6 in the absence and presence of peptide, there was 2-fold more CD8 ϩ cells in the presence of an initial dose of 10 -5 M peptide (Table 1) .
Agonist peptide induces optimal selection at low concentrations
Although positive selection was enhanced with 10 -5 M peptide added at the beginning of culture, there was marked apoptosis of the original double-positive cells within the first 24-48 h. We thus investigated the effects of lower LCMV peptide concentrations from 10 -7 to 10 -12 M LCMV over a 5 day coculture. In terms of the proportion and total number of selected CD4 -CD8 hi cells, peptide-enhanced positive selection using selecting H-2 b stroma was dose dependent with the optimal concentration being l0 -10 M with l0 -12 M still above stroma alone (Fig. 2) . When added once at the beginning of culture, there was a dose-dependent down-regulation of CD4 within the first 24 h resulting in apoptosis of the CD4 ϩ CD8 ϩ cells (data not shown). All concentrations, however, promoted positive selection as manifest by induction of CD4 -CD8 hi cells by day 3, in the presence of LCMV peptide, at least 1 day prior to cultures without peptide. Within the CD8 ϩ quadrant both CD4 -CD8 int and CD4 -CD8 hi populations were present with the former decreasing with lower concentrations of peptide; a ratio of 2-3:1 with 10 -7 M and 1:1 with 10 -12 M (data not shown). To assess the prolonged effects of a specific peptide concentration (since the peptide is degraded in culture), the co-cultures were pulsed daily with peptide con-centrations ranging from 10 -10 to 10 -14 M LCMV. Essentially the same effects on positive selection were observed with daily addition of peptide as for single doses at higher concentrations. For 10 -5 M LCMV, however, virtually all doublepositive cells apoptosed. As further proof of de novo positive selection, presorted CD4 ϩ CD8 ϩ E17 thymocyte precursors on a TAP-1-/-background were co-cultured with selecting H-2 b stroma; no pre-selection of CD8 T cells would have occurred prior to culture. In the absence of nominal peptide, positive selection again occurred, due to endogenous or FCS peptides. In the presence of 10 -5 M LCMV peptide, the majority of cells were negatively selected. This is reflected in the low numbers of selected CD8 T cells recovered from the co-cultures.
Up-regulation of the TCR as a consequence of positive selection
An important point to establish the validity of this model is the up-regulation of the TCR as a consequence of positive selection. This is clearly demonstrated in Fig. 3 . Prior to culture there were virtually no TCR hi cells as exemplified by V α 2 expression ( Fig. 3A) with identical profiles obtained for V β 8 expression (data not shown). In particular the CD4 ϩ CD8 ϩ and immature CD4 -CD8 ϩ cells showed low TCR expression. This is in contrast to transgenic CD4 -CD8 ϩ cells induced when co-cultured with selecting MHC stroma in the presence or absence of the nominal LCMV peptide which showed upregulation of V α 2 expression (Fig. 3B) and V β 8.1 (data not shown). Interestingly, 58% of CD4 -CD8 -cells post-co-culture in the presence of 10 -7 M LCMV peptide showed a high expression of the TCR (Fig. 3C ).
Positive selection with an agonist peptide produces functional CD8 T cells
The ultimate test for any model of positive selection is whether the selected single-positive T cells are functionally mature. For functional studies the stroma was generally irradiated (3000 rad) prior to culture to prevent any contribution from stroma-associated lymphocytes. Transgenic E17 P14 thymocytes (H-2 d ) were cultured alone or with thymic stroma from H-2 b (selecting MHC) in the absence or presence of 10 -10 M LCMV peptide. At day 5 the cells were harvested and cultured for a further 48 h in the presence of fresh antigen-presenting cells (APC) (irradiated H-2 b spleen cells) which had been pulsed with the same nominal LCMV peptide (10 -5 M). The selected cells that proliferated in response to the peptideloaded APC (Fig. 4A ) were able to specifically lyse LCMV peptide-loaded EL4 target cells (Fig. 4B ) and maintained their CD4 -CD8 ϩ(hi) phenotype (Fig. 4C) . The transgenic precursors cultured alone did not proliferate nor could they specifically lyse the peptide-loaded target cells. These data clearly demonstrate functional maturity of CD4 -CD8 ϩ cells selected on an agonist peptide.
Appearance of CD8 hi αβ populations at high doses of peptide
Within the CD4 -CD8 ϩ quadrant, two broad populations of cells are induced in this positive selection co-culture system: CD4 -CD8 hi and CD4 -CD8 int phenotypes, the latter appearing earlier in co-cultures containing the LCMV agonist peptide (e.g. day 3, Fig. 3 ). In view of the possible involvement of the CD8 co-receptor in positive selection, we investigated further the CD8αβ status in the co-cultures, with particular reference to the CD8 int and CD8 hi populations. In co-cultures containing 10 -10 to 10 -14 M of agonist peptide, most CD4 -CD8 hi cells expressed both the CD8 α and β chains (Fig. 5) . At higher concentrations, however, there was a profound increase in expression of the CD8 α chain, the ratio of CD8α:CD8β increasing from 1-2:1 to 5-6:1, this occurring from day 3 with 10 -8 M and even from day 2 with 10 -7 M LCMV peptide. With 10 -5 and 10 -6 M peptide, after the initial loss of double-positive thymocytes due to the high-avidity interactions between TCR and peptide-MHC, all CD4 -CD8 hi cells were of the CD8αα phenotype (data not shown).
To investigate the possibility that the CD8αα cells may represent non-mainstream T cells originating directly from CD4 -CD8 -cells, we positively sorted the E17 transgenic thymocyte precursors on CD4 expression, prior to culture, thereby eliminating the double-negative cells. These sorted cells were 90% CD4 ϩ CD8αβ ϩ and 10% immature CD4 ϩ single positives which converted to CD4 ϩ CD8αβ ϩ cells within 48 h (see Fig. 1A ). By day 5, in the absence of peptide, CD8 hi cells were of the CD8αβ phenotype. In the presence of 10 -8 M and more so in the presence of 10 -6 M LCMV peptide, the CD8 hi cells were of the CD8αα (CD8β -) phenotype (Fig. 6) . The CD8 int cells in the absence of peptide or at concentrations Ͻ10 -8 M were predominantly CD8αβ ϩ ; at higher concentrations there was a progressive increase in the CD8αα phenotype. CD4 -CD8 -cells also developed post-culture of sorted CD4 ϩ CD8αβ ϩ , suggesting that they had down-regulated their entire CD8 co-receptor; again they showed increased TCR expression (as in Fig. 3C ).
Discussion
Engagement of the TCR is a pivotal step in thymocyte development, ultimately resulting in the survival (positive selection) or loss (negative selection) of developing T cells. The role of peptides presented in the context of self MHC in shaping the T cell repertoire, and that of the stromal cell interactions both at a cellular and molecular level necessary for these selection events, are relatively poorly understood yet critical to elucidating the intricacies of T cell development.
Positive selection can occur in the absence of the nominal peptide when the transgenic cells on a non-selecting (H-2 d ) or TAP-1-deficient background respectively are co-cultured with H-2 b thymic stroma, presumably by the presentation of endogenous thymic peptides. The inability of EL4 cells to promote proliferation of the T cells positively selected in the stromal co-cultures indicates the endogenous peptide is thymic derived and not from the FCS used in the cultures. The identity of the thymic peptide(s) presented by the thymic stroma is unknown but presumably will be a variant of the LCMV peptide, retaining the D b binding motifs.
The presence of the nominal LCMV peptide clearly results in a greater percentage of cells being 'rescued' from preprogrammed death as well as inducing apoptosis at higher concentrations. The nominal peptide also influenced the rate of induction of de novo CD4 -CD8 ϩ cells which appeared 24 h earlier in cultures containing peptide, most likely through increasing the number of selecting peptide-MHC complexes available to the developing T cells.
The nominal LCMV peptide enhanced positive selection in a dose-dependent manner with 10 -10 M being optimal in terms of total numbers of selected CD8 cells, similar to that found by Sebzda et al. (3) . Positive selection was also enhanced at higher concentrations (10 -5 to 10 -7 M) compared to co-cultures without peptide; however, with these doses negative selection was initially evident by the typical apoptosis profile of CD4 lo CD8 lo . The appearance of both positive selection and negative selection with high concentrations of peptide is probably a result of the dynamics of the system. Doublepositive cells in contact with high concentrations of peptide are induced to apoptose almost immediately, as shown in the kinetics studies with 10 -5 M LCMV peptide. As peptide is added only once at the beginning of culture, by the time CD4 -CD8 -cells at day 0 mature into CD4 ϩ CD8 ϩ cells by day 2-3, less peptide is available due to uptake and/or the proteases in the FCS, converting the concentration from a deleting to a positively selecting dose. This is supported by the fact that the co-cultures are able to support the differentiation of pre-sorted double-negative cells to doublepositive cells and, in the presence of selecting stroma, the further differentiation into CD4 -CD8 ϩ cells. Positive selection was observed at peptide concentrations of 10 -5 M by AshtonRickardt et al. (24) and at 10 -12 M by Sebzda et al. (3) . The discrepancy probably lies in the fact that Sebzda et al. added peptide daily and did not use FCS in their culture medium, whereas Ashton-Rickardt et al. added FCS to culture medium and peptide was not added daily. In our system wild-type levels of MHC exist. When we added peptide daily at concentrations of 10 -5 M, there was apoptosis of all double-positive cells. At lower daily concentrations such as 10 -10 to 10 -14 M, the kinetics of positive selection were enhanced and the percentage of selected cells increased.
When E17 transgenic T cells (H-2 d ) were co-cultured with H-2 b thymic stroma in the absence or presence of 10 -10 M LCMV peptide, the positively selected transgenic CD8 T cells were able to proliferate when stimulated with fresh H-2 b APC pulsed with the same agonist peptide (at higher concentrations) used to induce positive selection. They were also able to specifically lyse target EL4 cells which had been prepulsed with the agonist peptide. CD8 T cells induced in the presence of 10 -7 and 10 -5 M were also functional (data not shown). Transgenic cells cultured alone or with non-selecting stroma both in the absence or presence of LCMV peptide, however, did not differentiate beyond the double-positive phenotype and were unable to specifically lyse peptideloaded target cells. Not only does this clearly show that positive selection only occurs in the presence of thymic stroma expressing the selecting MHC, but also that the selected CD8 ϩ cells were functionally mature, and that the agonist peptide at different concentrations and in different environments was able to induce positive and negative selection and activation.
The contribution of the CD8 co-receptor to the avidity of TCR-peptide-MHC interactions during thymic selection has been well documented. By increasing CD8 expression on thymocytes in MHC class I-restricted transgenic mice such as the H-Y TCR transgenic system, positive selection was enhanced (25) but in the 2C TCR transgenic system, increased CD8 expression resulted in a conversion from positive selection to negative selection (26, 27) . By decreasing the contribution of CD8, Sherman et al. (28) found that the TCR affinity threshold necessary for positive and negative selection was increased. Furthermore, in TCR transgenic mice the level of CD8 expressed on peripheral T cells varies with different MHC molecules and their peptide binding properties (29) . Collectively these findings are consistent with the downmodulation of CD8β we observed when high but non-deleting doses of LCMV peptide were added to the co-cultures; this would avoid excessive signaling and hence apoptosis due to the high-affinity interaction between the TCR and agonist peptide-MHC complex. Although variable, some down-modulation of CD8 does appear in the absence of peptide in our co-culture system. This is possibly due to higher avidity interactions from the greater stromal cell to thymocyte ratio compared to a normal thymus.
CD8β has also been shown to contribute to thymic selection both in the avidity of MHC-peptide-TCR interactions and possibly in signaling through its cytoplasmic domain. In CD8-deficient anti-HY TCR transgenic mice, impaired positive selection is found (13) . Similarly, a reduction in positively selected T cells in the MHC class I-restricted anti-HY TCR was found when a dominant negative mutation in the CD8 cytoplasmic tail was introduced (14) . However no effect was seen in the F5 TCR transgenic system, the conclusion being that CD8 does play a role in thymic selection but individual TCR may differ in their requirements (14) . Positive selection in our co-cultures produced three distinct populations of cells: CD4 -CD8 hi , CD4 -CD8 int and CD4 -CD8 -phenotypes, the majority of which showed high expression of the transgenic TCR. At low concentrations of nominal peptide virtually all CD8 ϩ T cells were of the CD4 -CD8 hi (CD8αβ) phenotype. At intermediate doses of peptide, CD8 int cells were of the CD8αβ phenotype; however, the CD8 hi cells were mostly of the CD8αα phenotype. At higher doses, such as 10 -5 M LCMV peptide, CD8 -, CD8 int αα and CD8 hi αα cells were increasingly evident.
Interestingly, CD8 down-modulation has also been observed with the ovalbumin-specific TCR system (7, 30) . High concentrations (l0-100 nM) of nominal ovalbumin peptide induced negative selection due to the high-affinity interaction between the ovalbumin-specific TCR and agonist peptide-MHC complex. Also evident at these concentrations, however, were TCR hi CD8 lo and CD4 -CD8 -cells (7) . These were also present with the A2 peptide which is a single amino acid variant of the ovalbumin agonist peptide, but at higher concentrations, presumably reflecting the lower TCR affinity to the variant peptide.
It has been shown that T cell activation can induce CD4 -CD8 -T cells to differentiate into CD8αα homodimers in various species (31, 32) and it has been suggested that doublepositive cells which are becoming double-negative cells may differentiate into activation-induced CD8αα T cells (33) . We have shown, by initially cell sorting for CD4 ϩ CD8 ϩ transgenic precursors, that the CD8αα cells can originate from CD4 ϩ CD8αβ ϩ cells. Although not obvious in the kinetics studies, whether there is a rapid transient CD4 -CD8 -stage, however, cannot yet be excluded. Hence this population of CD8αα cells results from direct regulation of the co-receptor in response to agonist peptide and not from the positive selection of a particular cellular population.
In view of the clear involvement of the CD8 co-receptor in positive selection and that this process involves sustained interactions with the thymic microenvironment (34), the logical explanation for the down-modulation of the CD8β chain would be to avoid over-reactivity and hence tolerance through deletion. Thus for TCR-peptide-MHC complex interactions of high affinity as in the case of an agonist peptide, T cells which have undergone initial phases of positive selection, and are still within the window of positive selection, can both qualitatively and quantitatively regulate their co-receptors to minimize any subsequent over-reactivity. This is summarized in Fig. 7 . Hence at low agonist peptide concentrations or low-avidity interactions, the cells undergo positive selection producing CD8 hi αβ cells. With increasing peptide concentrations (and avidity) there is a transition to the CD8 int αβ phenotype and to the CD8 hi αα phenotype. This may be followed by complete down-regulation of the CD8 co-receptor evident by the increased number of TCR hi CD4 -CD8 -cells after coculture. We are currently investigating the functional properties of these cells, particularly in the light of recent research showing that the majority of T cells isolated during early stages of experimental autoimmune encephalomyelitis, and thought to be precursors of lesion-forming T cells, were TCRαβ ϩ CD4 -CD8 -thymocytes which after culture expressed CD4 molecules (35) . At the highest peptide concentrations, thymocytes undergo apoptosis (Fig. 7) . Such a scheme could have important implications in the development of some autoimmune diseases. If during the window of positive selection a developing T cell contacts relatively high, but nondeleting levels of self-peptide (with agonist properties), autoreactive cells could potentially be positively selected. Also, if the developing T cell fails to quantitatively or qualitatively modulate the CD8 co-receptor, it may result in peripheral T cells with a lower TCR activation threshold. This abnormality could be inherent to the T cell itself or to the signaling received from the thymic stromal cells or defects in antigen presentation. In this regard, prominent thymic microenvironment defects have been found in several models of autoimmunity including lupus-prone NZB and mrl/lpr mice (36,37), L200 chickens which develop scleroderma (38) , and obesestrain chickens which are a model for Hashimoto's thyroiditis (39) .
In summary, positive selection can occur in the absence of the nominal peptide when the transgenic precursors [from non-selecting (H-2 d ) or TAP-1-/-(H-2 b ) background] are cocultured with fresh H-2 b thymic stroma, most likely by the presentation of endogenous peptides as happens in vivo. However, the presence of low concentrations of nominal LCMV peptide enhances positive selection presumably by increasing the number of available peptide-MHC complexes. With increasing concentrations of nominal peptide and hence greater avidity of TCR-peptide-MHC interactions, negative selection is increasingly evident. That the same peptide can induce activation in mature selected T cells is further evidence in support of an avidity model for thymic selection also involving co-stimulatory molecules. Furthermore, the downmodulation of the CD8 co-receptor and the CD8β chain to avoid over-reactivity at non-deleting doses of peptide illustrates the ability of the cells to modulate surface receptors both qualitatively and quantitatively in peptide-driven interactions. This has important implications in the potential for autoreactive cells to be positively selected.
